Telmisartan

Telmisartan: Long Duration of Action & the Question of When to Take It

Telmisartan is a sartan (AT1 receptor blocker) and lowers blood pressure by blocking the effect of the messenger angiotensin II. It has the longest duration of action in its group and therefore also covers the early morning hours, when blood pressure rises most sharply. Alongside lowering blood pressure it protects the kidneys, particularly in type 2 diabetes with protein in the urine.

See more detail

Take telmisartan at the same time every day

Reminder, intake history and blood pressure readings in one place — free in the brite app.

Track telmisartan

1. At a Glance: Technical Data Sheet

PropertyDetails
Active substanceTelmisartan
ATC codeC09CA07
Substance classAT1 receptor blocker (“sartan”, angiotensin II receptor antagonist)
Available formsTablets, usually 20 mg, 40 mg and 80 mg; in addition fixed combinations with hydrochlorothiazide or amlodipine
Half-lifeAround 24 hours — the longest value within the sartans
Maximum daily dose80 mg according to the Summary of Product Characteristics; your individual dose is set by your doctor
Onset of actionA first drop in blood pressure within hours, the full effect usually only after four to eight weeks
EliminationAlmost entirely through the bile and the stool, hardly at all through the kidneys; practically without any involvement of the CYP enzymes
Prescription statusPrescription-only in Germany
Special featureThanks to its long duration of action it also covers the early morning hours; no typical dry cough as seen with ACE inhibitors
Table scrolls to the right

2. How it works: why telmisartan lasts so long

Your body regulates blood pressure and its salt and water balance through the renin-angiotensin-aldosterone system. The decisive messenger in it is angiotensin II: it narrows the blood vessels and, through the hormone aldosterone, makes the kidneys hold on to sodium and water. Both push blood pressure up.¹

Telmisartan occupies the docking site for this messenger, the AT1 receptor. The vessels stay wider, the kidneys excrete more sodium, blood pressure falls. Because the receptor is blocked rather than — as with an ACE inhibitor — the formation of angiotensin II, telmisartan acts at a later point in the same chain.

What explains the long duration of action

Telmisartan is highly fat-soluble, which means it distributes well into the tissues, binds firmly to the receptor and only releases it slowly. The result is a half-life of around 24 hours — considerably longer than with most other sartans. In practice that means the effect is still comparatively stable shortly before the next tablet is due. For many people the early morning hours fall into exactly that window, the time when blood pressure naturally rises most sharply.¹

Three things follow directly from this mechanism and shape everyday life on telmisartan:

  • Kidney protection: pressure inside the filtering units of the kidney drops and protein loss into the urine goes down. That is why sartans are preferred in chronic kidney disease and in type 2 diabetes with protein in the urine.
  • Potassium rises: less aldosterone means the kidneys excrete less potassium. This is the most important lab observation on telmisartan.
  • No bradykinin effect: ACE inhibitors let the messenger bradykinin build up, which triggers the familiar dry, tickly cough. According to current evidence sartans do not do this — more on that in section 9.
A frequently quoted side benefit — to be taken with a pinch of salt. In the laboratory telmisartan also acts weakly on a metabolic switch called PPAR-gamma. A favourable effect on blood sugar and fat metabolism was once inferred from this. To this day that has not turned into a clinically robust advantage over other sartans.

3. Dosage: starting low and adjusting

The following describes what the Summary of Product Characteristics sets out as the usual approach. It is not a recommendation on how to take it — your dose is set by your doctor and adjusted from there.

  • Starting dose: frequently 40 mg once daily. In older people, when fluid levels are low, when diuretics are being taken or when liver function is impaired, treatment starts lower.
  • Range: as a rule 20 to 80 mg daily, always as a single dose; maximum dose 80 mg according to the Summary of Product Characteristics.
  • Increases: usually no earlier than after several weeks — before that it is simply not possible to judge what the current dose is achieving.
  • Combination: if one substance is not enough, a calcium channel blocker such as amlodipine or a thiazide such as hydrochlorothiazide is usually added — often as a fixed two-drug combination.
Patience is part of the treatment. Many people measure after three days, are disappointed and stop. But blood pressure falls slowly on telmisartan, and the full effect often only shows after several weeks. How to measure properly at home — and which measuring mistakes are the most common — is explained in the guide measuring blood pressure correctly.

4. Taking it: meals, routine, a missed dose

Telmisartan is uncomplicated in everyday life. The most important points, in the order of their practical weight:

  1. Pick a fixed time of day — and stick to it. Regularity beats any optimising of the clock; which time is the right one is dealt with in section 6.
  2. Meals barely matter. Food slightly lowers the amount absorbed, but not noticeably. You can take the tablet with or without food — just not one way one day and the other way the next.
  3. Only open the blister just before you take it. Telmisartan tablets are sensitive to moisture. Decanting whole packs in advance into an open pill organiser is not a good idea with this substance — see storing medications correctly.
  4. Stand up slowly in the first few days. Blood pressure can drop more sharply while the dose is being adjusted; dizziness when getting up is typical then and usually temporary.
  5. A missed dose: because of the long duration of action, a single forgotten tablet leaves nothing like the gap it would with short-acting blood pressure medicines. That is still not a free pass — several omissions in a row reliably let blood pressure climb again. What applies in general is set out in the guide forgot your blood pressure medication.
  6. Do not pause on your own initiative. Good readings are the result of the treatment — not the end of it.
Take care with diarrhoea, vomiting and heat. If you lose a lot of fluid, blood pressure can fall sharply on telmisartan and kidney function can suffer — particularly together with diuretics such as furosemide or torasemide. Talk such phases through with your practice instead of simply carrying on. Background in the guide medications and heat.

See your readings and your intake side by side

So that at your next appointment it is clear what actually worked.

Start your health record

5. Side effects and what helps against them

Telmisartan is considered comparatively well tolerated; most complaints occur while the dose is being adjusted and then ease off again.

More common and usually harmless

  • Dizziness and light-headedness — above all when standing up quickly and in the first few weeks. Getting up slowly and drinking enough usually helps; the guide dizziness from medications helps put it in context.
  • Fatigue — common at the start, often receding afterwards.
  • Headache and back pain — usually temporary.

Rarer, but important to know

  • Potassium too high (hyperkalaemia): often causes no symptoms at first, but can trigger heart rhythm problems. That is why it is monitored — see section 8.
  • Worsening kidney values: a slight rise in creatinine after treatment starts is known and usually acceptable; a sharp rise is a warning sign.
  • Muscle complaints and calf cramps — more common when a diuretic is taken as well.
Seek medical help immediately. Sudden swelling of the lips, tongue, face or throat, or difficulty breathing or swallowing, raises the suspicion of angioedema — that is an emergency, call 112 (the emergency number in Germany). Angioedema is very rare on sartans, but it does happen, even after a long time on treatment. Report unusual reactions afterwards; see medication side effects.

6. Morning or evening? What the evidence really shows

Hardly any question about blood pressure medicines is asked as often — and hardly any is answered in such a muddled way. The honest short version: for most people the time of day matters less than regularity.

Where the debate comes from

Blood pressure follows a daily rhythm: in most people it falls at night and rises markedly again in the early morning hours. Because heart attacks and strokes cluster in exactly that window, it seemed an obvious idea to give blood pressure medicines in the evening. A large Spanish study appeared to confirm this impressively — but after heavy methodological criticism it was retracted and can no longer be used as an argument. An independent British study on the timing of doses then found no difference between taking them in the morning and in the evening, as far as heart attacks, strokes and deaths are concerned. A general recommendation for evening dosing cannot be derived from this.¹,²

No switching on your own. Discuss any shift in the timing with your practice — and do not move half your medication list at the same time. Measure for one to two weeks before and after the change, otherwise you will not know afterwards what actually changed: measuring blood pressure correctly.

Where telmisartan has the advantage

This is where the long duration of action pays off: because the concentration stays comparatively even over 24 hours, the morning gap is smaller from the outset than with short-acting substances. The question of “morning or evening” loses some of its sting as a result. Sometimes your practice will choose evening dosing deliberately — for example when 24-hour monitoring shows that blood pressure does not fall at night. That is an individual decision based on a measurement, not a general rule.

In practice that means: choose the time of day you can keep up in the long run — ideally tied to an existing habit. Do not change it every few weeks because something different is being recommended online.

7. Interactions: the NSAID trap, potassium, lithium

Telmisartan is barely broken down by the CYP enzymes of the liver — the classic metabolic conflict with other tablets therefore plays a smaller role. Almost all of the relevant interactions come down to two questions: what happens to potassium? And what happens to blood flow through the kidneys?

CombinationConsequenceWhat to do
NSAIDs (e.g. ibuprofen, diclofenac, naproxen)The blood-pressure-lowering effect is weakened, kidney function can sufferOnly short term and after checking first; discuss alternatives such as paracetamol or metamizole
A sartan plus an NSAID plus a diuretic at the same timeClearly increased risk of acute kidney failure — the so-called triple whammyHave this three-way combination checked specifically by your doctor or pharmacist, especially in hot weather and during infections
Potassium-sparing diuretics such as spironolactone, potassium supplements, potassium-based salt substitutesPotassium can rise to dangerous levelsOnly with monitoring of the potassium value; avoid potassium-based salt substitutes
LithiumLithium levels can riseClose monitoring of blood levels
An ACE inhibitor such as ramipril or aliskiren in additionMore kidney problems and more rises in potassium without additional benefitDual blockade is as a rule deliberately avoided
AlcoholStronger fall in blood pressure, more dizzinessBe cautious, especially while the dose is being adjusted
Table scrolls to the right

The triple whammy in detail

The practically most important combination is the one in the second row — and it almost always comes about by accident. A sartan lowers the pressure inside the filtering units of the kidney. A diuretic such as furosemide additionally reduces the volume of fluid. If a painkiller from the NSAID group is added, it narrows the vessels leading into the kidney. All three effects together can push filtration down so far that acute kidney failure results — particularly during a stomach bug, a heatwave or a spell of drinking too little.

The catch: NSAIDs are available without a prescription and are not perceived by many people as “real” medicines. That is exactly why this combination rarely shows up on medication lists. Check it in the guide drug interactions or directly in the interaction check of the brite app. What generally applies with impaired kidney or liver function is covered under medications with kidney and liver disease.

The sentence that gets you somewhere at the pharmacy counter: “I take a sartan and a diuretic — does this painkiller fit with that?” On the subject of alcohol, see medications and alcohol.


8. Kidney protection and lab values: potassium, creatinine, protein

In type 2 diabetes with early kidney damage, a sartan or an ACE inhibitor is part of standard treatment, because both slow the loss of protein into the urine and can slow the progression of kidney weakness.³

The three values that count

  • Potassium: tends to rise on sartans. A value that is too high causes no symptoms at first, but it is the most common reason to change the dose or the accompanying medication.
  • Creatinine and eGFR: a measure of the filtering performance of the kidney. A slight rise straight after treatment starts is to be expected and does not argue against the treatment.
  • Protein in the urine (albumin-to-creatinine ratio): the real indicator of success for kidney protection. If it falls on treatment, the treatment is working where it is meant to.

The usual pattern is baseline values before starting, a check in the first weeks and after every dose increase, plus regular checks as treatment goes on — and additional ones when there is a reason: diarrhoea, vomiting, fever, a heatwave or new painkiller treatment. How to make sense of your results is explained in the guide understanding blood values; on kidney disease itself there is the article chronic kidney disease.

Potassium-rich food is not forbidden. You do not have to cut out bananas, dried fruit and nuts on telmisartan, as long as your kidney function is in order. What does deserve attention are potassium-based salt substitutes and food supplements containing potassium — they deliver large amounts unnoticed. See also supplements and medications.

9. Telmisartan compared: sartans and ACE inhibitors

All sartans work through the same mechanism. The differences lie mainly in how long they act, in their approved indications and in a few practical details.

Active substanceSpecial featurePractically relevant
TelmisartanLongest duration of action in the group, eliminated through the bileGood 24-hour cover; not suitable in severe liver impairment
CandesartanAlso a long duration of action, very fine dose stepsFrequently used in high blood pressure and in heart failure
ValsartanBroad evidence base after a heart attack and in heart failureAlso available in combination with sacubitril
LosartanShortest duration of action, lowers uric acid slightlyAn argument with gout; the 24-hour cover is weaker
Table scrolls to the right

No dry cough — the most common reason for switching

The classic reason to switch from an ACE inhibitor such as ramipril or enalapril to a sartan is a persistent dry cough. This cough is not a cold: dry, tickly, often worse at night — and it does not go away as long as the ACE inhibitor is being taken. The cause is the messenger bradykinin, which builds up on ACE inhibitors and irritates the cough receptors. Telmisartan acts at a different point and, according to current evidence, does not trigger this effect.¹

Two things often come as a surprise when switching. The cough can linger for days or a few weeks after the ACE inhibitor is stopped — that does not mean the switch has failed. And the requirements for potassium and kidney monitoring stay exactly the same; a sartan is not a “gentler” medicine. As a rule the two groups are not combined with each other.

In high blood pressure, sartans and ACE inhibitors are comparable in their blood-pressure-lowering effect. For people at high cardiovascular risk or with coronary heart disease, telmisartan additionally holds an authorisation for the prevention of cardiovascular events. Which substance fits in an individual case is decided by your doctor on the basis of accompanying conditions such as heart failure, kidney values and how well it is tolerated.


10. Special situations: pregnancy, older age, liver and kidneys

Absolutely not in pregnancy. Sartans are not suitable in pregnancy or when trying to conceive without reliable contraception — they can seriously harm the unborn child, particularly from the second trimester onwards: kidney failure in the child, too little amniotic fluid, malformations of the skull. Talk to your practice promptly about switching — but do not stop anything on your own, because untreated high blood pressure is dangerous in pregnancy too. Orientation is offered by medications during pregnancy.

While breastfeeding telmisartan is not recommended; there are better studied alternatives for that.

In older age treatment usually starts lower and is increased more slowly, because drops in blood pressure raise the risk of falls. One advantage of the long duration of action: it stays at one tablet a day. If you take several medicines at once, you will find orientation under medications in old age and polypharmacy.

With impaired kidney function telmisartan is not forbidden — on the contrary, it is frequently used precisely then. Because it is hardly excreted through the kidneys, a dose adjustment is usually not needed; it does, however, require closer monitoring of potassium and eGFR. If both renal arteries are narrowed, it is not suitable.

With liver disease caution is needed, because telmisartan is eliminated through the bile. In severe liver impairment or obstruction of the bile ducts it must not be used according to the Summary of Product Characteristics; in mild to moderate impairment the dose is capped.


11. Telmisartan experiences: what patients really ask

“I don't feel anything at all — is it even working?”

High blood pressure usually does not hurt, and so treating it feels like nothing at all. That is normal and no sign that the medicine is not working. The only reliable evidence is measured readings over several weeks — always at the same time of day, at rest. A record you can show at your appointment is worth more than the feeling of individual days. Approaches through lifestyle can be found under lowering blood pressure naturally.

“I forgot yesterday's tablet — is that bad?”

Because of the half-life of around 24 hours, a single missed dose is less dramatic than with short-acting blood pressure medicines: the next day a relevant part of the substance is still in the body. But that is exactly what tempts people to let it slide more often. Anyone who regularly forgets two or three tablets a week is effectively on a lower dose — and is then puzzled by rising readings. Taking double the amount the next day is not a solution.

“Can I stop telmisartan if my readings are good?”

Good readings are the result of the treatment. If it ends, blood pressure rises again — usually not abruptly but over weeks, which obscures the connection. Reducing the dose is possible in some situations, after significant weight loss for example. That decision belongs to your doctor: stopping medications.

“My doctor switched me to a combination tablet — am I taking more now?”

With fixed combinations the amount of telmisartan frequently stays the same; two substances at a low dose often work better than one at the maximum dose. The only important thing is that you do not accidentally carry on taking the old single tablet as well (generics vs. brand-name medicines). And yes: exercise is part of the treatment — but in heat and with heavy sweating, blood pressure medicines make dizziness more likely (medications and exercise).

Ibuprofen alongside a sartan? Check first.

The interaction check shows critical combinations before you take them.

Check the combination

FAQ: Common questions about telmisartan

A first drop in blood pressure sets in within hours, but according to the Summary of Product Characteristics the full effect usually only shows after four to eight weeks. That is why the dose is normally not adjusted earlier. Judge the effect from readings taken over several weeks, not from individual days.
According to current evidence there is no general recommendation for evening dosing. A much quoted study with a clear advantage for the evening was retracted, and a large independent study found no difference. What is decisive is regularity. You should discuss any change with your practice, particularly if 24-hour monitoring has been carried out.
Because of the half-life of around 24 hours, a relevant share of the substance is still in the body after a missed dose, so blood pressure does not rise sharply straight away. Taking double the amount the next day is still not a solution. Forgetting repeatedly effectively amounts to underdosing, which is why a fixed routine or a reminder is worth having.
No. ACE inhibitors let the messenger bradykinin build up, and it irritates the cough receptors. Telmisartan instead blocks the receptor for angiotensin II and does not affect bradykinin. That is why switching to a sartan is the usual solution for ACE inhibitor cough. A cough from another cause can of course still occur.
Occasionally and briefly this is acceptable for many people, but not on a permanent basis. NSAIDs weaken the blood-pressure-lowering effect and put a strain on the kidneys. Particularly critical is the three-way combination of a sartan, a diuretic and an NSAID, which can trigger acute kidney failure. So discuss painkillers with your doctor or pharmacist.
In type 2 diabetes with protein in the urine, sartans and ACE inhibitors are part of standard treatment, because they slow the loss of protein and can slow the progression of kidney weakness. What is monitored for this is potassium, creatinine or eGFR, and the albumin-to-creatinine ratio in the urine. The choice and the intervals between checks are set by your doctor.

Sources

  1. Summary of Product Characteristics (SmPC) for telmisartan, current version, available via the medicines information system of the licensing authorities (Germany). pharmnet-bund.de
  2. gesundheitsinformation.de, German Institute for Quality and Efficiency in Health Care (IQWiG): High blood pressure — treatment with medicines. Accessed 2026. gesundheitsinformation.de
  3. German National Disease Management Guideline on type 2 diabetes (BÄK, KBV, AWMF, reg. no. nvl-001, current version) — German source. awmf.org
  4. German S3 guideline on cardiovascular risk counselling in general practice (DEGAM), together with the AWMF guidelines on arterial hypertension — German source. awmf.org
  5. Embryotox, Charité — pharmacovigilance and advisory centre (Germany): sartans in pregnancy and while breastfeeding. Accessed 2026. embryotox.de
  6. gesund.bund.de (German national health portal): High blood pressure and kidney health. Accessed 2026. gesund.bund.de

Manage telmisartan safely day to day — with brite

Reminder, blood pressure history and interaction check in one place. Free.

Create medication plan
brite App
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or treatment. Never stop telmisartan on your own initiative and do not move the time you take it on your own — not even when your blood pressure readings are good. If you notice swelling of the face or throat, shortness of breath, or if you suspect you are pregnant, contact a doctor promptly or, in an emergency, call 112 (the emergency number in Germany). The choice of medicine and the dose are always determined individually by the treating practice. Last updated: August 2026.